Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Símbolo de cotizaciónBMRA
Nombre de la empresaBiomerica Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Zackary S. Irani
Número de empleados63
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección17571 Von Karman Avenue
CiudadIRVINE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92614
Teléfono19493792875
Sitio Webhttps://biomerica.com/
Símbolo de cotizaciónBMRA
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoMr. Zackary S. Irani
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos